vs

Side-by-side financial comparison of JOHNSON OUTDOORS INC (JOUT) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Tarsus Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($151.7M vs $140.9M, roughly 1.1× JOHNSON OUTDOORS INC). JOHNSON OUTDOORS INC runs the higher net margin — -2.3% vs -5.5%, a 3.2% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs 30.9%). Tarsus Pharmaceuticals, Inc. produced more free cash flow last quarter ($13.0M vs $-42.7M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs -10.5%).

Johnson Outdoors Inc. produces outdoor recreational products such as watercraft, diving equipment, camping gear, and outdoor clothing. It has operations in 24 locations worldwide, employs 1,400 people and reports sales of more than $315 million. Helen Johnson-Leipold, one of Samuel Curtis Johnson, Jr.'s four children, has run the company since 1999.

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

JOUT vs TARS — Head-to-Head

Bigger by revenue
TARS
TARS
1.1× larger
TARS
$151.7M
$140.9M
JOUT
Growing faster (revenue YoY)
TARS
TARS
+97.5% gap
TARS
128.4%
30.9%
JOUT
Higher net margin
JOUT
JOUT
3.2% more per $
JOUT
-2.3%
-5.5%
TARS
More free cash flow
TARS
TARS
$55.7M more FCF
TARS
$13.0M
$-42.7M
JOUT
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
-10.5%
JOUT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
JOUT
JOUT
TARS
TARS
Revenue
$140.9M
$151.7M
Net Profit
$-3.3M
$-8.4M
Gross Margin
36.6%
Operating Margin
-2.1%
-5.3%
Net Margin
-2.3%
-5.5%
Revenue YoY
30.9%
128.4%
Net Profit YoY
78.4%
63.8%
EPS (diluted)
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JOUT
JOUT
TARS
TARS
Q1 26
$140.9M
Q4 25
$135.8M
$151.7M
Q3 25
$118.7M
Q2 25
$180.7M
$102.7M
Q1 25
$168.3M
$78.3M
Q4 24
$107.6M
$66.4M
Q3 24
$105.9M
$48.1M
Q2 24
$172.5M
$40.8M
Net Profit
JOUT
JOUT
TARS
TARS
Q1 26
$-3.3M
Q4 25
$-29.1M
$-8.4M
Q3 25
$-12.6M
Q2 25
$7.7M
$-20.3M
Q1 25
$2.3M
$-25.1M
Q4 24
$-15.3M
$-23.1M
Q3 24
$-34.3M
$-23.4M
Q2 24
$1.6M
$-33.3M
Gross Margin
JOUT
JOUT
TARS
TARS
Q1 26
36.6%
Q4 25
36.2%
Q3 25
Q2 25
37.6%
Q1 25
35.0%
Q4 24
29.9%
Q3 24
23.5%
Q2 24
35.8%
Operating Margin
JOUT
JOUT
TARS
TARS
Q1 26
-2.1%
Q4 25
-6.0%
-5.3%
Q3 25
-12.2%
Q2 25
4.1%
-21.6%
Q1 25
2.9%
-33.5%
Q4 24
-18.8%
-36.8%
Q3 24
-40.4%
-52.3%
Q2 24
-0.3%
-81.6%
Net Margin
JOUT
JOUT
TARS
TARS
Q1 26
-2.3%
Q4 25
-21.4%
-5.5%
Q3 25
-10.6%
Q2 25
4.3%
-19.8%
Q1 25
1.4%
-32.1%
Q4 24
-14.2%
-34.8%
Q3 24
-32.4%
-48.7%
Q2 24
0.9%
-81.6%
EPS (diluted)
JOUT
JOUT
TARS
TARS
Q1 26
Q4 25
$-0.17
Q3 25
$-0.30
Q2 25
$-0.48
Q1 25
$-0.64
Q4 24
$-0.57
Q3 24
$-0.61
Q2 24
$-0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JOUT
JOUT
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$130.7M
$417.3M
Total DebtLower is stronger
$0
$72.4M
Stockholders' EquityBook value
$413.5M
$343.4M
Total Assets
$600.1M
$562.2M
Debt / EquityLower = less leverage
0.00×
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JOUT
JOUT
TARS
TARS
Q1 26
$130.7M
Q4 25
$176.4M
$417.3M
Q3 25
$401.8M
Q2 25
$161.0M
$381.1M
Q1 25
$94.0M
$407.9M
Q4 24
$101.6M
$291.4M
Q3 24
$162.0M
$317.0M
Q2 24
$148.4M
$323.6M
Total Debt
JOUT
JOUT
TARS
TARS
Q1 26
$0
Q4 25
$0
$72.4M
Q3 25
$72.3M
Q2 25
$0
$72.1M
Q1 25
$0
$72.0M
Q4 24
$0
$71.8M
Q3 24
$0
$71.7M
Q2 24
$0
$71.6M
Stockholders' Equity
JOUT
JOUT
TARS
TARS
Q1 26
$413.5M
Q4 25
$418.4M
$343.4M
Q3 25
$335.1M
Q2 25
$450.5M
$332.6M
Q1 25
$441.1M
$342.5M
Q4 24
$440.3M
$224.5M
Q3 24
$463.4M
$237.5M
Q2 24
$498.7M
$252.2M
Total Assets
JOUT
JOUT
TARS
TARS
Q1 26
$600.1M
Q4 25
$604.1M
$562.2M
Q3 25
$534.6M
Q2 25
$634.5M
$495.0M
Q1 25
$624.5M
$500.8M
Q4 24
$612.9M
$377.0M
Q3 24
$635.2M
$376.3M
Q2 24
$679.8M
$376.8M
Debt / Equity
JOUT
JOUT
TARS
TARS
Q1 26
0.00×
Q4 25
0.00×
0.21×
Q3 25
0.22×
Q2 25
0.00×
0.22×
Q1 25
0.00×
0.21×
Q4 24
0.00×
0.32×
Q3 24
0.00×
0.30×
Q2 24
0.00×
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JOUT
JOUT
TARS
TARS
Operating Cash FlowLast quarter
$-38.4M
$19.3M
Free Cash FlowOCF − Capex
$-42.7M
$13.0M
FCF MarginFCF / Revenue
-30.3%
8.6%
Capex IntensityCapex / Revenue
3.0%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$38.5M
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JOUT
JOUT
TARS
TARS
Q1 26
$-38.4M
Q4 25
$23.4M
$19.3M
Q3 25
$18.3M
Q2 25
$71.4M
$-29.4M
Q1 25
$-1.7M
$-20.7M
Q4 24
$-36.9M
$-22.2M
Q3 24
$19.1M
$-8.7M
Q2 24
$73.7M
$-14.4M
Free Cash Flow
JOUT
JOUT
TARS
TARS
Q1 26
$-42.7M
Q4 25
$19.2M
$13.0M
Q3 25
$16.3M
Q2 25
$66.9M
$-30.4M
Q1 25
$-5.0M
$-21.2M
Q4 24
$-41.0M
$-22.3M
Q3 24
$13.5M
$-8.9M
Q2 24
$67.4M
$-15.4M
FCF Margin
JOUT
JOUT
TARS
TARS
Q1 26
-30.3%
Q4 25
14.2%
8.6%
Q3 25
13.8%
Q2 25
37.0%
-29.6%
Q1 25
-2.9%
-27.1%
Q4 24
-38.1%
-33.5%
Q3 24
12.8%
-18.6%
Q2 24
39.1%
-37.8%
Capex Intensity
JOUT
JOUT
TARS
TARS
Q1 26
3.0%
Q4 25
3.1%
4.2%
Q3 25
1.6%
Q2 25
2.5%
1.0%
Q1 25
2.0%
0.8%
Q4 24
3.8%
0.1%
Q3 24
5.3%
0.6%
Q2 24
3.6%
2.5%
Cash Conversion
JOUT
JOUT
TARS
TARS
Q1 26
Q4 25
Q3 25
Q2 25
9.22×
Q1 25
-0.72×
Q4 24
Q3 24
Q2 24
45.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JOUT
JOUT

Fishing Segment$112.1M80%
Diving Segment$18.0M13%
Camping Watercraft Recreation Segment$10.6M8%

TARS
TARS

Segment breakdown not available.

Related Comparisons